STOCK TITAN

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Alpha Tau Medical (NASDAQ: DRTS, DRTSW), developer of the Alpha DaRT® alpha-radiation cancer therapy, has announced its participation in four upcoming investor conferences. CFO Raphi Levy will present at the following events:

1. H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, in New York, NY
2. Sidoti Small-Cap Virtual Investor Conference on September 19, 2024 (virtual)
3. Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26, 2024, in New York, NY
4. Lytham Partners Fall 2024 Investor Conference on October 1, 2024 (virtual)

Mr. Levy will be available for one-on-one investor meetings at all conferences. Interested parties should contact their respective conference representatives to schedule meetings.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+2.29%
1 alert
+2.29% News Effect

On the day this news was published, DRTS gained 2.29%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

JERUSALEM, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present a corporate overview and update at the H.C. Wainwright 26th Annual Global Investment Conference on September 10th, 2024 and in the Sidoti Virtual Investor Conference on September 18-19th, 2024 and will participate in the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26th, 2024 and the Lytham Partners Fall 2024 Investor Conference on October 1st, 2024.

Event:H.C. Wainwright 26th Annual Global Investment Conference
Date:September 10, 2024
Time:12:00 – 12:30PM EST
Location:New York, NY


Event:Sidoti Small-Cap Virtual Investor Conference
Date:September 19, 2024
Time:11:30AM – 12:00PM EST
Location:Virtual


Event:Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference
Date:September 26, 2024
Time:8:30AM – 2:30PM EST
Location:New York, NY


Event:Lytham Partners Fall 2024 Investor Conference
Date:October 1, 2024
Time:8:00AM – 7:00PM EST
Location:Virtual


Mr. Levy will be available for 1x1 investor meetings at all conferences. Please reach out to your H.C. Wainwright, Sidoti, Rothschild & Co, or Lytham Partners representatives to schedule.

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.

Investor Relations Contact: IR@alphatau.com


FAQ

When is Alpha Tau Medical (DRTS) presenting at the H.C. Wainwright Global Investment Conference?

Alpha Tau Medical (DRTS) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, from 12:00 – 12:30 PM EST in New York, NY.

Which investor conferences will Alpha Tau Medical (DRTS) participate in during Fall 2024?

Alpha Tau Medical (DRTS) will participate in four investor conferences in Fall 2024: H.C. Wainwright Global Investment Conference, Sidoti Small-Cap Virtual Investor Conference, Redburn Atlantic and Rothschild & Co Radiopharma Conference, and Lytham Partners Fall Investor Conference.

Who will represent Alpha Tau Medical (DRTS) at the upcoming investor conferences?

CFO Raphi Levy will represent Alpha Tau Medical (DRTS) at the upcoming investor conferences, presenting corporate overviews and updates.

Are one-on-one meetings available with Alpha Tau Medical (DRTS) at these conferences?

Yes, CFO Raphi Levy will be available for one-on-one investor meetings at all four conferences. Interested parties should contact their respective conference representatives to schedule meetings.

What is the date and location of the Sidoti Small-Cap Virtual Investor Conference where Alpha Tau Medical (DRTS) is presenting?

Alpha Tau Medical (DRTS) is presenting at the Sidoti Small-Cap Virtual Investor Conference on September 19, 2024, from 11:30 AM – 12:00 PM EST. This conference is being held virtually.
Alpha Tau Medical Ltd

NASDAQ:DRTS

DRTS Rankings

DRTS Latest News

DRTS Latest SEC Filings

DRTS Stock Data

648.01M
57.38M
32.79%
2.28%
0.11%
Biotechnology
Healthcare
Link
Israel
Jerusalem